Navigation Links
Benign eye tumors being treated

Researchers at the University of Texas feel that they may have found an effective treatment for a type of non-cancerous eye tumor that threatens clear vision.// Using photodynamic therapy, researchers successfully restored vision in three patients who were suffering from intraocular choroidal hemangiomas, which involved serious retinal detachments.

Intraocular choroidal hemangiomas are benign tumors, which can cause symptoms due to their location, growth, and the accumulation of fluid in the eye. Doctors generally don't treat the tumors unless the problems lead to vision loss or a detached retina.

In these cases, each of the patients was suffering from a tumor in one eye, and all suffered loss of vision and a detached retina. In the first case, a 60 year old man attempted reatment after experiencing decreased visual acuity in his right eye for two weeks. In the second case, a 40 year old man came to the clinic complaining of flickering lights and decreased visual acuity in his left eye. The third subject was a 65 year old man who had been initially diagnosed in 1995 and followed for the next 5 years, during which time he began to experience significantly worsening vision and an expanding central blind spot.

Researchers used photodynamic therapy to treat the detached retinas and shrink the tumors. Photodynamic therapy includes a light-sensitive dye that produces blood clots to terminate the growth of abnormal new blood vessels. In all three cases, the therapy resolved the detached retinas and shrunk the tumors beyond measurable size. Vision improved to 20/20 for the first two patients and to 20/200 for the third patient. After 10 months to 15 months of follow-up, none of the tumors had returned. Researchers conclude photodynamic therapy appears to be effective for the treatment of choroidal hemangioma.


'"/>




Page: 1

Related medicine news :

1. New Technique For Benign Breast Tumors
2. Another Treatment Option for Benign Tumors
3. ‘Benign’ MS May Not Be So Benin
4. Outpatient Treatment Kills Benign Bone Tumors Nonsurgically With Heat
5. Morphine may excite cancerous tumors
6. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
7. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
8. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
9. Same molecule found in meat, milk, tumors
10. Women with borderline ovarian tumors can still preserve their fertility
11. Surgery to remove tumors in the spine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... The American Board of Family Medicine's (ABFM) Board of ... Executive Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve ... Puffer’s retirement at the end of 2018. Upon assuming the role of President and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... , ... Many families have long-term insurance that covers care for a family ... for care if the client has a cognitive impairment diagnosis. , “What this ... often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, owner ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... ... 2017 , ... Coveros, a leader in agile coaching services ... by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile Transformation ... Agile methodologies in a consistent and high value manner across CMS programs. Coveros ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... MIAMI , Sept. 27, 2017  Commended for their ... recent notable awards. Ranked as number one in the South ... ninth time in Inc. 5000 yearly list, the national specialty ... CEO, Armando Bardisa will soon be honored by ... Set to receive his award ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: